Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Government Contract opportunity from Department Of Health And Human Services was posted on August 3, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

High-Throughput RNA Sequencing

Closed
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 541380
New
Federal
Aeration Blower and Silencer Vibration and Shock Fixture Fabrication
Solicitation # N6660426Q0459
Solicitation N66604-26-Q-0459 is a firm-fixed-price request for quotes from the Naval Undersea Warfare Center Division, Newport, for the fabrication and assembly of two specific test fixtures: one CHT Aeration Blower Fixture Assembly and one Discharge Silencer Fixture Assembly. The contractor is responsible for procuring materials, including copper-nickel piping, and performing welding and assembly to replicate a shipboard environment in accordance with Mil-DTL-901E and Mil-Std-167A. The work will be performed at the contractor's facility and at NUWCDIVNPT, where the contractor must provide on-site technical personnel to support government-executed fitment evaluations. Key deliverables include a Fabrication and Inspection Report due within five business days of assembly completion and a final Summary Report detailing fabrication and fitment testing. The desired delivery date for the assemblies is January 15, 2027, with delivery terms set as FOB Destination, Newport, RI. Award is based on the lowest price technically acceptable, with the government reviewing past performance via the Supplier Performance Risk System. Offerors must be registered in SAM, provide a CAGE code for drawing access, and achieve CMMC Level 2 (Self) certification prior to award. Quotes are due by September 11, 2026, and must include all shipping costs within the unit price.
Nuwc Division Newport

POSTED

about 13 hours ago

DEADLINE

in 7 days

AI Contract Overview

Show more

The contract calls for high-throughput RNA sequencing of 256 libraries using Illumina platforms, requiring each sample to yield between 15 and 30 million paired-end reads to ensure sufficient depth for robust transcriptomic analysis. All sequencing must result in demultiplexed FASTQ files accompanied by comprehensive quality metrics to validate data integrity and suitability for downstream bioinformatics processing. The work is classified as a subcontract under NAICS code 541380, indicating it falls within scientific research and development services, and is being managed by the FDA Office of Acquisition and Grant Services under the Department of Health and Human Services. The place of performance is designated as Jefferson, Arkansas, with a response deadline of August 10, 2026, and the opportunity was posted on August 3, 2026, indicating a competitive procurement timeline of one week for potential bidders to submit proposals.

General Info

High-throughput RNA sequencing of 256 libraries on Illumina platforms, 15–30M reads each, demultiplexed FASTQs, FDA subcontract, Jefferson, Arkansas, response due August 10, 2026.

Agency

Department Of Health And Human Services → FDA Office Of Acq Grant SvcsView Agency

NAICS

541380 - Testing Laboratories and ServicesView NAICS

Place of Performance

Jefferson, AR, 72079, USA

Set-Aside

NONE

Documents

This scope was carved out of 75F40126Q135715.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

Total Tissue Sample RNA Isolation, mRNA Library Preparation, Sequencing, and Bioinformatic Processing/Analysis

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseClosed
Posted

subcontract

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → FDA Office Of Acq Grant Svcs
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Health And Human Services → FDA Office Of Acq Grant Svcs
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Perform next-generation sequencing on 256 libraries to generate 15–30 million paired-end reads per sample using Illumina platforms, with demultiplexed FASTQ data delivery and quality metrics.

More opportunities from Department Of Health And Human Services → FDA Office Of Acq Grant Svcs

Same awarding agency

NAICS: 541714
New
Federal
Human Hindbrain Organoid Functional Assay Services.
Solicitation # RFQ_CDR-2026-135968
The U.S. Food and Drug Administration's Center for Drug Evaluation and Research intends to award a sole-source, firm-fixed-price purchase order to OrganoTherapeutics SARL for human induced pluripotent stem cell (iPSC)-derived hindbrain organoid functional assay services. The project aims to support in vitro research evaluating drug-induced effects on respiratory-relevant neural circuits over an eighteen-month period of performance. The scope of work is divided into two primary components: the provision of human hindbrain organoids and associated culture materials through twelve scheduled deliveries to the FDA White Oak Campus, and the performance of functional characterization services at the contractor's laboratory. Functional characterization will utilize three-dimensional multi-electrode array (3D MEA) technology to assess electrophysiological responses to FDA-identified drug and reversal-agent combinations. Deliverables include the delivery of 96 organoids in the first shipment followed by 48 organoids in subsequent deliveries, as well as raw data, analyzed data, analysis files, and comprehensive study reports. This acquisition is conducted as a commercial service under FAR Part 12, with the government restricting competition based on market research identifying OrganoTherapeutics SARL as the only source capable of meeting the complete requirement for both the specific organoid products and the associated functional assay services.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

about 13 hours ago

DEADLINE

in 6 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS